INZY Insider Trading

Insider Ownership Percentage: 11.19%
Insider Buying (Last 12 Months): $3,999,998.40
Insider Selling (Last 12 Months): $52,209.62

Inozyme Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Inozyme Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inozyme Pharma Share Price & Price History

Current Price: $4.51
Price Change: Price Increase of +0.11 (2.50%)
As of 05/29/2024 01:00 AM ET

This chart shows the closing price history over time for INZY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Inozyme Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/2/2024Douglas A TrecoCEOSell7,523$6.94$52,209.6220,665View SEC Filing Icon  
8/1/2023Pivotal Bioventure Partners FuDirectorBuy833,333$4.80$3,999,998.402,923,110View SEC Filing Icon  
5/11/2023Robert Lorne HopfnerDirectorBuy219,230$6.48$1,420,610.403,432,816View SEC Filing Icon  
3/29/2023Robert Lorne HopfnerDirectorBuy344,592$4.54$1,564,447.683,213,586View SEC Filing Icon  
3/27/2023Robert Lorne HopfnerDirectorBuy51,074$3.70$188,973.802,712,228View SEC Filing Icon  
12/15/2022Henric Bjorn BjarkeCOOBuy21,500$1.39$29,885.00105,441View SEC Filing Icon  
4/19/2022Axel BolteCEOBuy67,750$3.69$249,997.50258,575View SEC Filing Icon  
4/19/2022Henric Bjorn BjarkeCOOBuy27,100$3.69$99,999.0080,626View SEC Filing Icon  
4/19/2022Longitude Capital Partners IiiMajor ShareholderBuy1,355,000$3.69$4,999,950.004,174,379View SEC Filing Icon  
4/19/2022Robert Lorne HopfnerDirectorBuy1,070,000$3.69$3,948,300.002,661,154View SEC Filing Icon  
6/24/2021Axel BolteCEOSell66,788$0.00$0.00257,613View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Inozyme Pharma (NASDAQ:INZY)

88.30% of Inozyme Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at INZY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Inozyme Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2024California State Teachers Retirement System4,799$37K0.0%-38.9%0.008%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC437,657$3.35M0.1%+52.2%0.708%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC2,642,519$20.24M2.5%+40.1%4.272%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,419,020$18.53M0.0%+1.4%3.911%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC13,926$0.11M0.0%-34.4%0.023%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP131,098$1M0.1%-21.5%0.212%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC3,179,837$13.55M0.2%+1.8%5.149%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP400,000$1.70M0.3%-69.2%0.648%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP123,944$0.53M0.4%N/A0.201%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC1,885,802$8.03M1.5%+36.7%3.053%Search for SEC Filing on Google Icon
1/19/2024Denali Advisors LLC22,000$94K0.0%-17.6%0.036%Search for SEC Filing on Google Icon
1/18/2024Values First Advisors Inc.13,898$59K0.0%N/A0.023%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC21,236$90K0.0%+46.9%0.034%Search for SEC Filing on Google Icon
11/15/2023Rock Springs Capital Management LP3,681,174$15.46M0.4%+7.4%5.960%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP677,329$2.85M0.0%+170.5%1.097%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.5,537,500$23.26M0.1%+30.3%8.966%Search for SEC Filing on Google Icon
11/15/2023Affinity Asset Advisors LLC1,379,852$5.80M1.6%+83.5%2.234%Search for SEC Filing on Google Icon
11/14/2023Eventide Asset Management LLC3,125,000$13.13M0.2%N/A5.060%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC311,880$1.31M0.0%+346.8%0.505%Search for SEC Filing on Google Icon
11/14/2023Pivotal bioVenture Partners Investment Advisor LLC4,494,851$18.88M7.5%+22.8%7.278%Search for SEC Filing on Google Icon
11/13/2023CHI Advisors LLC1,270,027$5.33M1.6%+6.3%2.056%Search for SEC Filing on Google Icon
11/13/2023FMR LLC2,465,232$10.35M0.0%+229.2%3.992%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund13,375$56K0.0%-21.8%0.022%Search for SEC Filing on Google Icon
10/26/2023Strs Ohio9,900$41K0.0%N/A0.016%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC14,452$61K0.0%N/A0.023%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC10,205$56K0.0%+62.7%0.017%Search for SEC Filing on Google Icon
8/22/2023CHI Advisors LLC1,195,027$6.66M2.0%-11.0%1.936%Search for SEC Filing on Google Icon
8/15/2023Sphera Funds Management LTD.1,131,967$6.31M1.0%-36.5%1.834%Search for SEC Filing on Google Icon
8/14/2023Deep Track Capital LP1,644,021$9.16M0.4%-49.4%2.663%Search for SEC Filing on Google Icon
8/14/2023Rock Springs Capital Management LP3,428,084$19.09M0.5%+6.6%5.553%Search for SEC Filing on Google Icon
8/11/2023Pivotal bioVenture Partners Investment Advisor LLC3,661,518$20.40M6.7%+13.9%5.932%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC57,468$0.32M0.0%N/A0.124%Search for SEC Filing on Google Icon
8/4/2023Parallel Advisors LLC15,427$86K0.0%-22.3%0.033%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.16,292$91K0.0%N/A0.035%Search for SEC Filing on Google Icon
7/18/2023Denali Advisors LLC26,700$0.15M0.1%N/A0.061%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC751,796$4.31M1.4%+50.4%1.718%Search for SEC Filing on Google Icon
5/11/2023CHI Advisors LLC1,342,191$7.69M2.0%-39.1%3.067%Search for SEC Filing on Google Icon
5/11/2023Knott David M Jr160,000$0.92M0.4%N/A0.366%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC46,995$0.27M0.0%N/A0.107%Search for SEC Filing on Google Icon
2/10/2023NEA Management Company LLC2,437,689$2.56M0.1%-0.3%6.035%Search for SEC Filing on Google Icon
11/14/2022UBS Oconnor LLC165,498$0.44M0.0%-3.4%0.412%Search for SEC Filing on Google Icon
8/16/2022Deerfield Management Company L.P. Series C2,696,372$12.86M0.3%+15.0%6.724%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP271,800$1.30M0.0%+2,618.0%0.678%Search for SEC Filing on Google Icon
8/15/2022Pivotal bioVenture Partners Investment Advisor LLC2,661,154$12.69M6.4%+67.2%6.637%Search for SEC Filing on Google Icon
8/11/2022Bioimpact Capital LLC664,980$3.17M0.9%+125.4%1.658%Search for SEC Filing on Google Icon
8/11/2022Overbrook Management Corp69,326$0.33M0.1%+314.5%0.173%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC101,442$0.48M0.0%N/A0.253%Search for SEC Filing on Google Icon
2/15/2022Laurion Capital Management LP13,390$91K0.0%-81.1%0.057%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.1,599,028$10.91M0.0%+8.9%6.757%Search for SEC Filing on Google Icon
2/14/2022Suvretta Capital Management LLC1,013,216$6.91M0.1%+2.7%4.281%Search for SEC Filing on Google Icon
2/11/2022Bioimpact Capital LLC302,615$2.06M0.4%-5.6%1.279%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp120,762$0.82M0.0%+4.0%0.510%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund3,834$26K0.0%-63.3%0.016%Search for SEC Filing on Google Icon
11/16/2021Suvretta Capital Management LLC986,400$11.43M0.2%+170.1%4.168%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP364,600$4.23M0.0%-50.0%1.541%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP70,700$0.82M0.0%N/A0.299%Search for SEC Filing on Google Icon
11/16/2021BioImpact Capital LLC320,724$3.72M0.6%N/A1.355%Search for SEC Filing on Google Icon
11/16/2021CHI Advisors LLC920,264$10.67M3.1%-0.8%3.889%Search for SEC Filing on Google Icon
11/15/2021Deerfield Management Company L.P. Series C2,344,786$27.18M0.5%+7.6%9.910%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP850,015$9.85M0.2%+1.2%3.592%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP33,408$0.39M0.0%-16.9%0.141%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP135,398$1.57M0.0%N/A0.572%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC198,624$2.30M0.0%+10.5%0.839%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.115,516$1.34M0.0%+4,518.8%0.488%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund10,453$0.12M0.0%+18.8%0.044%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC11,611$0.14M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP40,202$0.69M0.0%-22.4%0.170%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC61,313$1.05M0.0%-58.9%0.259%Search for SEC Filing on Google Icon
8/17/2021Burrage Capital Management LLC242,517$4.13M4.1%+43.1%1.025%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC171,066$2.92M0.0%-28.8%0.723%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System19,867$0.34M0.0%+9.5%0.084%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.61,917$1.06M0.0%+4.1%0.262%Search for SEC Filing on Google Icon
8/16/2021State Street Corp169,889$2.90M0.0%+28.5%0.718%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC47,394$0.81M0.0%+122.6%0.200%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.19,310$0.33M0.0%-18.8%0.082%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP40,202$0.69M0.0%-22.4%0.170%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp120,743$2.06M0.0%+4.6%0.514%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC179,672$3.06M0.0%+19.5%0.765%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.335,286$5.71M0.0%-1.7%1.428%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.16,659$0.28M0.0%-21.9%0.071%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp36,546$0.62M0.0%+56.6%0.156%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.899,873$15.34M0.0%+4.4%3.832%Search for SEC Filing on Google Icon
8/10/2021Citigroup Inc.2,108$36K0.0%+69.3%0.009%Search for SEC Filing on Google Icon
8/5/2021Rhumbline Advisers12,787$0.22M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/4/2021Russell Investments Group Ltd.2,501$42K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund8,802$0.15M0.0%-28.4%0.037%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC149,205$2.95M0.0%N/A0.635%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC240,401$4.76M0.0%-4.8%1.024%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System18,143$0.36M0.0%+47.5%0.077%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C1,964,000$38.89M0.8%+70.7%8.363%Search for SEC Filing on Google Icon
5/17/2021Rock Springs Capital Management LP827,900$16.39M0.4%-0.3%3.526%Search for SEC Filing on Google Icon
5/17/2021Suvretta Capital Management LLC341,427$6.76M0.1%+59.3%1.454%Search for SEC Filing on Google Icon
5/17/2021Caas Capital Management LP177,502$3.52M0.0%N/A0.756%Search for SEC Filing on Google Icon
5/17/2021Novo Holdings A S1,969,379$38.99M1.6%-23.4%8.386%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.23,790$0.47M0.0%+14.2%0.101%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp23,337$0.46M0.0%+9.3%0.099%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.1,245$25K0.0%-44.3%0.005%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp115,469$2.29M0.0%+24.4%0.492%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC150,361$2.98M0.0%+41.3%0.641%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.21,324$0.42M0.0%+455.9%0.091%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Inozyme Pharma logo
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Read More on Inozyme Pharma

Today's Range

Now: $4.51
Low: $4.37
High: $4.52

50 Day Range

MA: $5.23
Low: $4.33
High: $7.66

52 Week Range

Now: $4.51
Low: $2.69
High: $7.80

Volume

354,513 shs

Average Volume

568,993 shs

Market Capitalization

$278.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Who are the company insiders with the largest holdings of Inozyme Pharma?

Inozyme Pharma's top insider investors include:
  1. Robert Lorne Hopfner (Director)
  2. Pivotal Bioventure Partners Fu (Director)
  3. Henric Bjorn Bjarke (COO)
  4. Douglas A Treco (CEO)
Learn More about top insider investors at Inozyme Pharma.

Who are the major institutional investors of Inozyme Pharma?

Inozyme Pharma's top institutional investors include:
  1. Affinity Asset Advisors LLC — 4.27%
  2. Vanguard Group Inc. — 3.91%
  3. Kennedy Capital Management LLC — 0.71%
  4. GSA Capital Partners LLP — 0.21%
  5. SG Americas Securities LLC — 0.02%
  6. California State Teachers Retirement System — 0.01%
Learn More about top institutional investors of Inozyme Pharma stock.

Which institutional investors are selling Inozyme Pharma stock?

Within the previous quarter, INZY stock was sold by these institutional investors:
  1. GSA Capital Partners LLP
  2. SG Americas Securities LLC
  3. California State Teachers Retirement System

Which institutional investors are buying Inozyme Pharma stock?

Within the previous quarter, INZY stock was bought by institutional investors including:
  1. Affinity Asset Advisors LLC
  2. Kennedy Capital Management LLC
  3. Vanguard Group Inc.
In the previous year, these company insiders have bought Inozyme Pharma stock:
  1. Robert Lorne Hopfner (Director)
  2. Pivotal Bioventure Partners Fu (Director)
  3. Henric Bjorn Bjarke (COO)
Learn More investors buying Inozyme Pharma stock.